Kura Oncology, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: KURA
Kura Oncology, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker KURA. It has reported private securities offerings to the US SEC, most recently $150 million sold in a notice filed in 2024.
Kura Oncology at a glance
What does Kura Oncology do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $150 million sold (2024).
Frequently asked questions about Kura Oncology
Where is Kura Oncology headquartered?
Kura Oncology, Inc. is headquartered in San Diego, California, United States.
What does Kura Oncology do?
Kura Oncology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Kura Oncology a public company?
Yes. Kura Oncology, Inc. trades on Nasdaq under the ticker KURA.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.